Home/Curovir/Nina Lindblom, PhD
NL

Nina Lindblom, PhD

Head of Clinical and Business Development

Curovir

Curovir Pipeline

DrugIndicationPhase
CUR-N399Broad-spectrum Enterovirus InfectionsPre-clinical
PleconarilType 1 Diabetes (exploratory)Research